AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Cash and Cash Equivalents

Annual Cash & Cash Equivalents:

$77.39M-$92.81M(-54.53%)
December 31, 2024

Summary

  • As of today, AMLX annual cash & cash equivalents is $77.39 million, with the most recent change of -$92.81 million (-54.53%) on December 31, 2024.
  • During the last 3 years, AMLX annual cash & cash equivalents has risen by +$27.20 million (+54.19%).
  • AMLX annual cash & cash equivalents is now -54.53% below its all-time high of $170.20 million, reached on December 31, 2023.

Performance

AMLX Cash and Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Quarterly Cash & Cash Equivalents:

$343.99M+$163.16M(+90.23%)
September 30, 2025

Summary

  • As of today, AMLX quarterly cash & cash equivalents is $343.99 million, with the most recent change of +$163.16 million (+90.23%) on September 30, 2025.
  • Over the past year, AMLX quarterly cash & cash equivalents has increased by +$109.59 million (+46.76%).
  • AMLX quarterly cash & cash equivalents is now -7.85% below its all-time high of $373.29 million, reached on March 31, 2024.

Performance

AMLX Quarterly Cash & Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

AMLX Cash and Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-54.5%+46.8%
3Y3 Years+54.2%+111.6%
5Y5 Years+2425.0%+2571.3%

AMLX Cash and Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-54.5%+54.2%-7.8%+111.6%
5Y5-Year-54.5%+2425.0%-7.8%+2571.3%
All-TimeAll-Time-54.5%+2425.0%-7.8%+2571.3%

AMLX Cash and Cash Equivalents History

DateAnnualQuarterly
Sep 2025
-
$343.99M(+90.2%)
Jun 2025
-
$180.83M(-11.4%)
Mar 2025
-
$204.07M(+15.6%)
Dec 2024
$77.39M(-54.5%)
$176.50M(-24.7%)
Sep 2024
-
$234.40M(-24.3%)
Jun 2024
-
$309.81M(-17.0%)
Mar 2024
-
$373.29M(+0.5%)
Dec 2023
$170.20M
$371.36M(+4.6%)
Sep 2023
-
$355.05M(-0.6%)
DateAnnualQuarterly
Jun 2023
-
$357.28M(+3.4%)
Mar 2023
-
$345.67M(-0.4%)
Dec 2022
$62.53M(+24.6%)
$346.94M(+113.4%)
Sep 2022
-
$162.59M(-21.3%)
Jun 2022
-
$206.68M(-19.0%)
Mar 2022
-
$255.21M(+165.5%)
Dec 2021
$50.19M(+289.8%)
$96.12M(+646.4%)
Dec 2020
$12.88M(+320.1%)
$12.88M
Dec 2019
$3.06M
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual cash & cash equivalents?
  • What is the all-time high annual cash & cash equivalents for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly cash & cash equivalents?
  • What is the all-time high quarterly cash & cash equivalents for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of AMLX is $77.39M

What is the all-time high annual cash & cash equivalents for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $170.20M

What is Amylyx Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?

Over the past year, AMLX annual cash & cash equivalents has changed by -$92.81M (-54.53%)

What is Amylyx Pharmaceuticals, Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of AMLX is $343.99M

What is the all-time high quarterly cash & cash equivalents for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $373.29M

What is Amylyx Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, AMLX quarterly cash & cash equivalents has changed by +$109.59M (+46.76%)
On this page